JMAC vs. QFTA, CERO, BENF, HAIA, EFHT, PBM, DMAQ, NIVF, NSTC, and MCAE
Should you be buying Maxpro Capital Acquisition stock or one of its competitors? The main competitors of Maxpro Capital Acquisition include Quantum FinTech Acquisition (QFTA), CERo Therapeutics (CERO), Beneficient (BENF), Healthcare AI Acquisition (HAIA), EF Hutton Acquisition Co. I (EFHT), Psyence Biomedical (PBM), Deep Medicine Acquisition (DMAQ), NewGenIvf Group (NIVF), Northern Star Investment Corp. III (NSTC), and Mountain Crest Acquisition Corp. III (MCAE). These companies are all part of the "holding & other investment offices" industry.
Quantum FinTech Acquisition (NYSE:QFTA) and Maxpro Capital Acquisition (NASDAQ:JMAC) are both small-cap unclassified companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings.
Quantum FinTech Acquisition's return on equity of 0.00% beat Maxpro Capital Acquisition's return on equity.
30.5% of Quantum FinTech Acquisition shares are held by institutional investors. Comparatively, 73.2% of Maxpro Capital Acquisition shares are held by institutional investors. 2.4% of Quantum FinTech Acquisition shares are held by company insiders. Comparatively, 19.3% of Maxpro Capital Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Quantum FinTech Acquisition and Maxpro Capital Acquisition both received 0 outperform votes by MarketBeat users.
In the previous week, Maxpro Capital Acquisition had 1 more articles in the media than Quantum FinTech Acquisition. MarketBeat recorded 1 mentions for Maxpro Capital Acquisition and 0 mentions for Quantum FinTech Acquisition. Maxpro Capital Acquisition's average media sentiment score of 0.00 equaled Quantum FinTech Acquisition'saverage media sentiment score.
Quantum FinTech Acquisition has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500. Comparatively, Maxpro Capital Acquisition has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500.
Summary
Maxpro Capital Acquisition beats Quantum FinTech Acquisition on 5 of the 6 factors compared between the two stocks.
Get Maxpro Capital Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for JMAC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JMAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Maxpro Capital Acquisition Competitors List
Related Companies and Tools
